Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment
Abstract Background Recent intravesical administration of adenoviral vectors, either as a single injection or in combination with immune checkpoint inhibitors, exemplified by cretostimogene grenadenorepvec and nadofaragene firadenovec, has demonstrated remarkable efficacy in clinical trials for non-...
Saved in:
| Main Authors: | Dae Hoon Lee, Jung Ki Yoo, Ki Hwan Um, Wootae Ha, Soo Min Lee, Junseong Park, Min Jeong Kye, Jungyo Suh, Jin Woo Choi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-06-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-024-03088-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment
by: Dae Hoon Lee, et al.
Published: (2025-07-01) -
A comprehensive map of the mTOR signaling network
by: Etienne Caron, et al.
Published: (2010-12-01) -
Prognostic Significance of mTOR Expression in Recurrence Following Hepatic Metastasectomy in Colorectal Cancer
by: Fuat Aksoy, et al.
Published: (2025-05-01) -
As a New Tumor Suppressor Gene, PID1 Activates the AMPK-mTOR Signal to Inhibit the Progression of Bladder Cancer
by: Sun L, et al.
Published: (2025-07-01) -
Porphyra haitanensis polysaccharide (PH) attenuates cell hyperplasia via remodeling the cross-talk between Hippo/YAP and mTOR pathways
by: Chong Wang, et al.
Published: (2023-03-01)